At the end of last year, we welcomed Dr. Markus Pfuhl, Managing Director of the Viessmann Foundation gGmbH, to our foundation. As part of a reorientation of the Viessmann Foundation’s philanthropic focus, we introduced him to the research priorities at the Dr. Petra Joh Research Center. He was particularly impressed by the RCCL, the “Resistant Cancer Cell Line Collection.” A globally unique cell bank of over 3,000 cancer cell lines made resistant, which allows us to address the therapeutic problem of resistance that would otherwise be impossible in young patients. It takes about a year to make a cancer cell line resistant, meaning over 3,000 years of work have gone into this cell bank, which is stored in nitrogen-filled cryogenic tanks at -196 degrees Celsius. At the beginning of this year, we received the great news that the Viessmann Foundation would be providing substantial support to the cell bank for three years.

In addition to Dr. Markus Pfuhl, Byung-Hun Park, VP of Corporate Communications, was present at the handover. Further opportunities for collaboration were explored at the photo opportunity, so we look forward to a long-term partnership with the Viessmann Foundation. We would also like to expressly thank Max Viessmann and the entire team for their support!

Photo (from left): Byung-Hun Park, VP Corporate Communications, Viessmann Generations Group; Dr. Markus Pfuhl, Managing Director, Viessmann Foundation gGmbH; Dr. Daniela Golz, Marketing & Public Relations; Uwe Menger, Board Member; Marcus Klüssendorf, Managing Director (all, Frankfurt Foundation for Children with Cancer)